Package Leaflet: Information for the User
Symbicort 80micrograms/2.25micrograms/inhalation inhalation suspension in a pressurised inhaler
Budesonide/formoterol fumarate dihydrate
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack
What Symbicort is
Symbicort is an inhaler used to treat asthma in adults and adolescents from 12 to 17 years of age. It contains two different medicines: budesonide and formoterol fumarate dihydrate.
What Symbicort is used for
Symbicort is used to treat asthma and may be prescribed alone or with another inhaler "for relief of symptoms" to be used separately:
Some patients are prescribed two inhalers for asthma: the Symbicort inhaler and another separate "reliever" inhaler
Some patients are prescribed Symbicort as their only asthma inhaler
How Symbicort works
Do not use Symbicort:
Warnings and precautions
Consult your doctor or pharmacist before you start using Symbicort if:
Consult your doctor if you experience blurred vision or other visual disturbances while using Symbicort.
Children
Do not use this medicine in children under 12 years of age.
Use in athletes
This medicine contains formoterol, which may produce a positive result in doping tests.
Other medicines and Symbicort
Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.
In particular, tell your doctor or pharmacist if you are using any of the following medicines:
If you are in any of these situations, or if you are not sure, ask your doctor or pharmacist before using Symbicort.
Tell your doctor or pharmacist if you are going to have a general anaesthetic for surgery or for dental treatment.
Pregnancy and breastfeeding
Driving and using machines
Symbicort has no or negligible influence on the ability to drive and use machines.
Follow the administration instructions for this medication exactly as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
Symbicort may be prescribed for asthma alone or with another reliever inhaler separately. You should take two inhalations of Symbicort to get a full dose. The amount of Symbicort you should use and when you should use it will depend on what you have been prescribed.
Use Symbicort daily. This helps prevent asthma symptoms.
Adults (over 18 years)
Adolescents (12 to 17 years)
Your doctor (or nurse) will help you manage your asthma. They will adjust the dose of this medication to the lowest dose that controls your asthma. However, do not adjust or stop the dose without talking to your doctor (or nurse) first.
Use your other "reliever inhaler" when asthma symptoms appear.
Use Symbicort in this way only if your doctor has told you to and if you are over 12 years old.
Use Symbicort daily. This helps prevent asthma symptoms from appearing. You can do:
Your doctor may increase the dose to 4 inhalations, twice a day.
Also, use Symbicort as a "reliever inhaler" to treat asthma symptoms when they appear and to prevent asthma symptoms from appearing (e.g., when exercising or exposed to allergens).
Always keep your Symbicort inhaler with you so you can use it when you need it.
Normally, a daily dose of more than 16 inhalations is not required. However, your doctor may allow you to take up to 24 inhalations per day for a limited period.
If you usually need to use 16 or more inhalations per day, go to your doctor or nurse, as you may need to change your treatment.
Do not take more than 24 inhalations in 24 hours.
If you are exercising and notice asthma symptoms, use Symbicort as described here. It is essential to talk to your doctor about using Symbicort to prevent asthma symptoms; both the frequency of exercise and exposure to allergens could influence the treatment prescribed to you.
Symbicort and steroid tablets
If you have been taking steroid tablets for asthma, your doctor may reduce the number of tablets you take once you start treatment with Symbicort. If you have been taking oral steroid tablets for a long time, your doctor may want to do a blood test from time to time. When the number of oral steroid tablets is reduced, you may feel unwell, even if your lung symptoms are improving. The symptoms can be:
Consult your doctor immediately if you experience symptoms such as:
If you experience any of the above symptoms, consult your doctor immediately; you may need to take another medication. Talk to your doctor if you are concerned about whether you should continue using Symbicort.
Use in children
There are other formulations of this medication suitable for children; consult your doctor or pharmacist.
Important information about your asthma symptoms
If, while using Symbicort, you feel short of breath or wheeze, you should continue using it and contact your doctor as soon as possible, as you may need additional treatment.
Consult your doctor immediately if:
Information about your new Symbicort inhaler
Preparing Symbicort
The inhaler needs to be prepared for use in the following situations:
To prepare the inhaler for use, follow these instructions:
How to take an inhalation
Each time you need to take an inhalation, follow these instructions:
Using a spacer chamber
Your doctor, nurse, or pharmacist may suggest using a spacer chamber (e.g., Aerochamber Plus Flow Vu or Aerochamber Plus). Follow the instructions provided with the spacer chamber.
Cleaning Symbicort
How do I know when to replace my Symbicort inhaler?
If you use more Symbicort than you should
It is essential to inhale your dose as indicated on the pharmacist's label or as your doctor has recommended. Do not use more doses than prescribed without consulting your doctor.
If you have used more Symbicort than you should, consult your doctor or pharmacist. The most common symptoms and signs that may occur after an overdose are tremors, headache, and rapid heartbeat.
In case of overdose or accidental ingestion, consult the Toxicology Information Service. Phone: 91 5620420, indicating the medication and the amount taken.
If you forget to use Symbicort
If you stop using Symbicort
Before stopping the use of Symbicort, you must consult your doctor or pharmacist. If you stop using Symbicort, your asthma symptoms may worsen.
If you have any other questions about using this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone gets them.
If you experience any of the following, stop using Symbicort and consult your doctor immediately:
Other possible side effects:
Common (may affect up to 1 in 10 patients)
Uncommon (may affect up to 1 in 100 patients)
Rare (may affect up to 1 in 1,000 patients)
Very rare (may affect up to 1 in 10,000 patients)
Inhaled corticosteroids may affect the normal production of steroid hormones in the body, especially if high doses are used for a long time. These effects include:
These effects are much less likely with inhaled corticosteroids than with corticosteroid tablets.
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Medicines Monitoring System: www.notificaRAM.es.
By reporting side effects, you can help provide more information on the safety of this medication.
Warning: The cartridge contains a pressurized liquid. Do not expose to temperatures above 50°C. Do not pierce the cartridge. The cartridge should not be broken, punctured, or burned, even when it appears to be empty.
Composition of Symbicort
The active ingredients are budesonide and formoterol fumarate dihydrate. Each inhaled dose contains 80 micrograms of budesonide and 2.25 micrograms of formoterol fumarate dihydrate.
The other excipients are apaflurane (HFA 227), povidone, and macrogol. This inhaler does not contain CFCs.
This medication contains fluorinated greenhouse gases. Each inhaler contains 10.8 g of apaflurane (HFC-227ea) which corresponds to 0.035 tons of CO2 equivalent (global warming potential GWP = 3,220).
Appearance of the product and container contents
Symbicort is an inhaler that contains your medication. The medication, a white-colored inhalation suspension, is presented in a pressure-resistant cartridge with an attached dose indicator. The cartridge is mounted on a red plastic adapter with a white plastic mouthpiece and an integrated gray plastic cap. Each inhaler contains 60 or 120 inhalations after it has been prepared for use. Each inhaler is individually packaged in an aluminum foil wrapper containing a desiccant.
Symbicort 80 micrograms/2.25 micrograms/inhalation inhalation suspension in a pressure-resistant container (budesonide/formoterol fumarate dihydrate) is available in containers with a single inhaler.
Only some package sizes may be marketed.
Marketing authorization holder and manufacturer
The holder is:
Laboratory AstraZeneca Pharmaceutical Spain, S.A.
C/ Puerto de Somport 21-23
28050 Madrid
Spain
The manufacturer is:
AstraZeneca Dunkerque Production
224, Avenue de la Dordogne BP 41
59640 Dunkerque (France)
This medication is authorized in the member states of the European Economic Area under the following names:
Austria: Symbicort 80 Mikrogramm/2,25 Mikrogramm/Inhalation Druckgasinhalation, Suspension; Belgium: Symbicort 80 microgram/2,25 microgram/inhalatie, aërosol, suspensie; Symbicort 80 microgrammes/2,25 microgrammes/inhalation, suspension pour inhalation en flacon pressurisé; Symbicort 80 Mikrogramm/2,25 Mikrogramm/Inhalation, Druckgasinhalation, Suspension; Bulgaria: ????????? 80 ??????????/2,25 ??????????/?????????? ????????? ??? ???????? ?? ?????????; Cyprus: Symbicort 80 μικρογραμμ?ρια/2,25 μικρογραμμ?ρια/ψεκασμ?; Croatia: Symbicort 80 mikrograma/2,25 mikrograma po potisku, stlaceni inhalat, suspenzija; Denmark: Symbicort 80 mikrogram/2.25 mikrogram/inhalation; Slovakia: Symbicort 80 mikrogramov/2,25 mikrogramov/inhalacná dávka, inhalacná suspenzia v tlakovom obale; Slovenia: Symbicort 80 mikrogramov/2,25 mikrograma na vdih, inhalacijska suspenzija pod tlakom; Spain: Symbicort 80 microgramos/2,25 microgramos/inhalación suspensión para inhalación en envase a presión; Estonia: Symbicort; Finland: Symbicort 80 mikrog/2.25 mikrog/inhalaatio; France: Symbicort 100/3 microgrammes par inhalation, suspension pour inhalation en flacon préssurisé; Greece: Symbicort 80 μικρογραμμ?ρια/2,25 μικρογραμμ?ρια/ψεκασμ?; Netherlands: Symbicort aërosol 100/3, 100 microgram/3 microgram per dosis, aërosol, suspensie; Hungary: Symbicort 2,25 mikrogramm/80 mikrogramm/ adag túlnyomásos inhalációs szuszpenzió; Iceland: Symbicort 80 míkrógrömm/2,25 míkrógrömm/ inhalation; Italy: Symbicort; Latvia: Symbicort 80 mikrogrami/2.25 mikrogrami/ inhalacija, izsmidzinajuma, aerosols inhalacijam zem spiediena; Lithuania: Symbicort 80 mikrogramu/2,25 mikrogramo/išpurškime suslegtoji ikvepiamoji suspensija; Luxembourg: Symbicort 80 microgrammes/2,25 microgrammes/inhalation, suspension pour inhalation en flacon pressurisé; Malta: Symbicort 100 micrograms/3 micrograms/inhalation, pressurised inhalation, suspension; Norway: Symbicort 80 mikrogram/2.25 mikrogram/ inhalasjon; Poland: Symbicort; Portugal: Symbicort 80 microgramas/2,25 microgramas/inalação Suspensão pressurizada para inalação; United Kingdom: Symbicort 100 micrograms/3 micrograms per actuation pressurised inhalation, suspension; Czech Republic: Symbicort 80 micrograms/2,25 micrograms/inhalation, suspension in pMDI; Romania: Symbicort 80 micrograme/2,25 micrograme/inhala?ie, suspensie de inhalat presurizata; Sweden: Symbicort 80 mikrogram/2.25 mikrogram/inhalation
Date of the last revision of this prospectus: January 2025
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of SYMBICORT 80 micrograms/2.25 micrograms/inhalation pressurized suspension for inhalation in October, 2025 is around 19.78 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.